CLINICAL_TRIALS
trial_result
· 2017-08-30
Clinical Trial Update: Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury [NA]
Summary
Memantine was studied for neuroprotection and cognitive enhancement after traumatic brain injury. The trial has completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Traumatic Brain Injury | NA | Status: COMPLETED | Results posted: 2017-08-30